Gaudenzia Hutchinson Place

Gaudenzia Hutchinson Place, based in Philadelphia, PA, is one of the SAMHSA-registered treatment programs operating in PA. The specific care levels offered by Gaudenzia Hutchinson Place should be confirmed directly with the admissions team. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at Gaudenzia Hutchinson Place

On care levels specifically: Care-level specifics for Gaudenzia Hutchinson Place are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. What that means in practice is that matching Gaudenzia Hutchinson Place to the right clinical situation depends on whether you or a loved one needs the level of care this facility actually offers — which is a clinician's judgment, not a facility's sales pitch.

Insurance and payment

Payment and insurance specifics for Gaudenzia Hutchinson Place are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Before you call

Before admission to Gaudenzia Hutchinson Place, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether Gaudenzia Hutchinson Place offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.